1. Japan Stocks

  2. •

    Process industries

  3. •

    Chemicals: major diversified
Nippon Shokubai Co., Ltd.

Nippon Shokubai Co., Ltd.

2,536.50
JPY
-35.00
(-1.36%)
335.41BMarket Cap
Nov 09Next Earn
Nippon Shokubai Co., Ltd.
TSE:4114
(Tokyo Stock Exchange)

Recent

price

2,536.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
1,882.38
1,974.75
1,659.65
1,860.62
2,308.9
1,990.42
1,815.8
1,968.02
2,124.41
1,894.26
1,712.58
2,315.32
2,641.12
2,509.89
2,680.42
2,675.29
- -
Revenue per Share
137.87
130.89
51.73
64.68
117.57
160.18
119.59
141.93
149.51
69.55
-68.33
148.71
122.07
70.48
113.9
112.15
- -
Basic EPS, GAAP
107.1
141.46
-14.16
-39.02
86.73
243.06
5.72
70.3
20.33
21.75
24.39
80.26
115.59
238.9
78.38
25.48
- -
Free Cash Flow per Basic Share
21.39
28.75
27.5
16.25
23.75
32.5
40.11
37.5
41.25
45
33.75
31.25
47.72
45.28
76.49
110.57
- -
Dividend per Share
1,173.33
1,251.93
1,324.8
1,455.13
1,633.91
1,717.68
1,809.58
1,937.52
2,024.98
2,004.28
1,989.75
2,156
2,303.47
2,482.44
2,527.98
2,684.47
- -
Book Value per Share
1,152.98
1,235.29
1,311.09
1,436.64
1,609.85
1,693.04
1,785.27
1,848.7
1,939.97
1,913.11
1,952.2
2,106.5
2,250.33
2,450.34
2,498.31
2,619.81
- -
Tangible Book Value per Share
153
162
162
162
162
162
162
160
160
160
160
160
159
156
153
149
149
Basic Weighted Avg Shares
288,345
320,704
269,520
302,136
374,873
323,124
293,970
313,939
338,869
302,150
273,163
369,293
419,568
392,009
409,346
399,898
- -
Sales/Revenue/Turnover
12.07
9.7
3.72
4.55
6.97
9.67
7.2
8.16
7.72
4.36
-5.83
7.87
5.61
4.23
4.66
4.38
- -
Operating Margin (%)
15,619
16,767
15,402
16,995
18,971
17,875
17,957
22,918
25,626
28,653
29,470
28,875
29,312
31,853
31,551
32,243
- -
Depreciation Expense
21,119
21,257
8,401
10,503
19,089
26,003
19,361
22,641
23,849
11,094
-10,899
23,720
19,392
11,008
17,394
16,764
- -
Net Income, GAAP
29.57
34.87
32.99
32.01
34.36
25.36
20.89
22.27
24.18
26.4
- -
27.33
22.98
21.4
20.47
18.6
- -
Effective Tax Rate (%)
7.32
6.63
3.12
3.48
5.09
8.05
6.59
7.21
7.04
3.67
-3.99
6.42
4.62
2.81
4.25
4.19
- -
Profit Margin (%)
79,035
77,591
74,843
75,206
100,520
114,629
97,664
107,849
107,543
112,332
101,056
128,642
142,412
158,433
148,280
143,376
- -
Working Capital
42,616
30,396
36,224
32,891
37,059
29,274
36,457
45,302
34,902
38,854
28,887
28,634
27,867
21,924
18,265
35,624
- -
LT Debt
194,266
209,070
220,248
242,193
270,128
282,485
292,275
316,188
329,227
326,109
323,725
351,123
369,998
392,562
392,534
406,588
- -
Total Equity
8.17
7.48
2.39
3.11
5.23
6.86
4.84
5.43
5.16
2.51
- -
5.37
4.35
3.03
3.48
3.15
- -
Return on Invested Capital (%)
8.51
8.08
3.14
3.54
5.96
7.83
5.77
6.3
6.33
3.11
- -
6.02
4.73
2.66
4.21
3.78
- -
Return on Capital (%)
12.05
10.77
4.01
4.65
7.61
9.56
6.82
7.58
7.55
3.45
-3.42
7.17
5.49
2.95
4.54
4.3
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
19,360
23,107
- -
LT Borrowings
24,311
35,624
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
149
148
148
Market Capitalization
271,304
335,408
307,890

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
238,063
247,243
- -
Cash, Cash Equivalents & STI
54,662
60,920
- -
Accounts Receivable, Net
92,363
91,288
- -
Inventories
83,988
85,758
- -
Total Current Liabilities
92,387
103,867
- -
Payables & Accruals
- -
- -
- -
ST Debt
19,360
23,107
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.76%
4.7%
3.58%
Free Cash Flow
120.1%
47.91%
-68.18%
Net Income, GAAP
-57.97%
-64.94%
-3.62%
Sales/Revenue/Turnover
2.96%
8.87%
-2.31%
Total Cash Common Dividend
15.39%
28.93%
41.49%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
409,346
2026
- -
- -
- -
- -
399,898
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
113.9
2026
- -
- -
- -
- -
112.15
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
76.49
2026
- -
- -
- -
- -
110.57
2027
- -
- -
- -
- -
- -
Similar Companies
Hektas Ticaret T.A.S. (BIST:HEKTS)
AARTI Industries Ltd (NSE:AARTIIND)
Aether Industries Ltd. (NSE:AETHER)
Mitsui & Co.,Ltd (TSE:8031)
Saudi Basic Industries Corp. (TADAWUL:2010)
Raghav Productivity Enhancers Ltd. (NSE:RPEL)
Business
Nippon Shokubai Co., Ltd. manufactures and sells a broad range of basic and specialty chemicals, synthetic resins, and catalysts primarily in Japan and internationally through its Materials Business and Solutions Business segments; core products include superabsorbent polymers such as AQUALIC CA and CS for hygiene and horticultural applications, acrylic acids and esters, maleic anhydride and derivatives like succinic acid and N-phenylmaleimide (IMILEX-P), ethylene oxide and glycols, ethanolamines, process catalysts for acrolein and ethylene oxide production, polycarboxylate ether polymers (AQUALOC) for concrete admixtures, oxazoline group-containing emulsions (EPOCROS K Series), polyethyleneimine (EPOMIN), secondary alcohol ethoxylates (SOFTANOL), automotive catalysts, De-NOx catalysts, dioxin decomposition catalysts, electrolyte materials for lithium-ion batteries (IONEL LF-101), acrylic resins for optical films (ACRYVIEWA), fine particles like EPOSTAR series and SEAHOSTAR silica, and polymers for color filters (ACRYCURE); the company also offers electronic information materials, pharmaceutical intermediates, water-soluble polymers, and contract development and manufacturing services for medium-sized molecule APIs including oligonucleotides and peptides. Founded in 1941 and headquartered in Osaka, Japan, with key facilities including the Tokyo Office, Kawasaki Plants (Chidori and Ukishima), Himeji Plant and Research Center, and Suita Research Center, Nippon Shokubai operates globally with exports to regions including the US, Europe, and Asia, targeting industries such as hygiene products, construction, automotive, electronics, pharmaceuticals, cosmetics, energy storage, and environmental treatment. In recent developments, the company completed the acquisition of Emulsion Technology Co., Ltd. (E-TEC) from JSR Corporation for ¥7.2 billion on April 1, 2025, to bolster its construction chemicals portfolio through E-TEC's emulsion polymerization and compounding technologies; it acquired all shares of Lilac pharma Inc. on December 9, 2024, making it a wholly-owned subsidiary to advance lipid nanoparticle (liposome) technologies like iLiNP Microfluidic Device for cosmetics and pharmaceuticals via joint R&D since 2019; additionally, Nippon Shokubai strengthened its domestic supply chain for lithium bis(fluorosulfonyl)imide (LiFSI) electrolytes in 2024 and published its TechnoAmenity Report 2024 emphasizing sustainability.